Company intelligence / Profile preview

Icarus Therapeutics

San Diego, California, United Statesicarustherapeutics.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Icarus Therapeutics has developed a global, next-generation platform that automates and optimizes the process of enrolling patients into clinical trials. The company focuses on democratizing access to studies—especially for underrepresented groups—and aims to accelerate the pace of research in aging-related diseases and cellular degeneration. It has been recognized as a BBB4Good Verified Business and is an active member of the California Life Sciences Association.

Therapeutic areas: OtherNeurology
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

California Life Sciences Association membership

Beyond the preview

Go deeper on Icarus Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Icarus Therapeutics.

Explore the full profile